TickerFactsScreenerDevelopers

KalVista Pharmaceuticals, Inc. (KALV) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $8.24M2013: $9.78M2014: $3.90M2015: $53.72M2016: $21.76M2017: $30.95M2018: $51.05M2019: $32.01M2020: $15.79M2021: $50.59M2022: $30.73M2023: $56.24M2024: $31.79M2025: $229.34M$229.34M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$229.34M+621.5%
2024$31.79M-43.5%
2023$56.24M+83.0%
2022$30.73M-39.3%
2021$50.59M+220.4%
2020$15.79M-50.7%
2019$32.01M-37.3%
2018$51.05M+65.0%
2017$30.95M+42.2%
2016$21.76M-59.5%
2015$53.72M+1278.6%
2014$3.90M-60.2%
2013$9.78M+18.7%
2012$8.24M—